Simplex Trading »

Cytek Biosciences shares owned by Simplex Trading

Quarter-by-quarter ownership of Cytek Biosciences (CTKB) shares owned by Simplex Trading from 13F filings

Historical chart of Simplex Trading investment in Cytek Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cytek Biosciences held by Simplex Trading consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytek Biosciences by Simplex Trading

Quarter filed Position value Share count Share price at filing
2024-03-31 $0 139 0.00
2023-12-31 $0 11 0.00

More positions owned by Simplex Trading

Spdr S&p 500 Etf Tr Put Put Option
Spdr S&p 500 Etf Tr Call Call Option
Invesco Qqq Tr Put Put Option
Nvidia Corporation Call Call Option
Nvidia Corporation Put Put Option
Invesco Qqq Tr Call Call Option
Ishares Tr Put Put Option
Tesla Put Put Option
Ishares Tr Call Call Option
Apple Call Call Option
Tesla Call Call Option
Select Sector Spdr Tr Put Put Option
Meta Platforms Call Call Option
Amazon Call Call Option
Apple Put Put Option

View all positions for Simplex Trading

Top funds holding Cytek Biosciences

Vanguard Group
RA Capital Management
Hillhouse Capital Advisors
New York State Common Retirement Fund
Wellington Management Company
Dimensional Fund Advisors
Charles Schwab Investment Management
Bank of New York Mellon
Goldman Sachs Group
Connor, Clark & Lunn Investment Management
Principal Financial Group
Rhumbline Advisers
Legal & General Group
State of Wisconsin Investment Board
Swiss National Bank

View all funds holding Cytek Biosciences